Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient Manufacturer
Condition: Herpes Zoster Interventions: Drug: Recombinant Human Interferon α-2b Gel (After the Alteration); Drug: Recombinant Human Interferon α-2b Gel (Before the Alteration) Sponsor: Lee's Pharmaceutical Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2023 Category: Research Source Type: clinical trials
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Conditions: Ovarian Cancer; Peritoneal Carcinomatosis; Fallopian Tube Cancer Intervention: Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors: Shanghai Yunying Medical Technology; Shanghai 10th People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2023 Category: Research Source Type: clinical trials
